Pacific Edge’s product benefits are compelling and seek to address a number of important current shortcomings in cancer detection and management, including the need for:

Earlier Detection

Pacific Edge has developed biomarker tests that detect early stage tumours, leading to the improved characterisation, treatment and management of cancer.

Non-Invasive Testing

RNA and protein assays, like those developed by Pacific Edge, are performed on body fluids such as urine or blood and are thus minimally invasive and pain-free.

Rule Out

A significant number of symptomatic and post-treatment surveillance patients do not have cancer. The biomarker test developed by Pacific Edge enable the accurate rule out of patients presenting with symptoms and those being monitored for recurrence, reducing the need for further invasive tests in some cases.